Balchem Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
Balchem Stock Forecast and Price Target
If the average 2024 price target of $163.00 recently set by prominent experts for Balchem is met, there would be a potential upside of approximately 4.46% from the last closing price in March, 2024. The high estimate is $165.00, and the low is $135.00. If you're looking for Balchem (BCPC) stock information, you might also want to check out Celanese (NYSE:CE).
4.46% Upside
Balchem Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Balchem's Price has fallen from $117.26 to $0.00 – a 100.00% decrease. The next year looks promising for Balchem, with analysts predicting Fair Value of $143.40 – an increase of 100.00%. Over the next seven years, experts anticipate that Balchem's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BAS Stock Forecast | BASF | Outperform |
12
|
49.06€ | Buy/Sell | 49.50€ | 4.97% |
2802 Stock Forecast | Ajinomoto | Outperform |
18
|
¥5.69k | Buy/Sell | ¥6.06k | -3.39% |
CE Stock Forecast | Celanese | Hold |
13
|
$157.43 | Buy/Sell | $148.23 | 1.63% |
EMN Stock Forecast | Eastman Chemical Co | Outperform |
11
|
$91.67 | Buy/Sell | $96.03 | 3.09% |
EVK Stock Forecast | Evonik Industries | Outperform |
18
|
16.98€ | Buy/Sell | 20.64€ | 17.79% |
Balchem Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's Revenue has grown, increasing from $703.64M to $922.44M – a growth of 31.10%. The next year looks promising for Balchem, with analysts predicting Revenue of $984.46M – an increase of 6.72%. Over the next seven years, experts anticipate that Balchem's Revenue will grow at a rate of 8.62%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
600299 Stock Forecast | Bluestar Adisseo | Outperform |
18
|
¥8.63 | Buy/Sell | ¥9.81 | 26.30% |
000830 Stock Forecast | Luxi Chemical Group | Buy |
16
|
¥10.01 | Buy/Sell | ¥13.72 | 21.48% |
300705 Stock Forecast | Hunan Jiudian Pharmaceutical | Buy |
16
|
¥37.21 | Buy/Sell | ¥36.00 | -100.00% |
Balchem Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's Dividend per Share has grown by 36.21%, from $0.58 to $0.79. In the following year, 0 experts forecast that Balchem's Dividend per Share will decrease by 9.79%, to $0.71. In 2030, professionals predict that Balchem's Dividend per Share will decrease by 10.27%, to $0.71.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
HWKN Stock Forecast | Hawkins | Outperform |
18
|
$65.27 | Buy/Sell | $52.00 | 13.38% |
UAN Stock Forecast | CVR Partners, LP |
17
|
$66.09 | Buy/Sell | $9.50 | -100.00% | |
GNC Stock Forecast | Greencore Group | Outperform |
15
|
£1.07 | Buy/Sell | £1.04 | -4.67% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LXU Stock Forecast | LSB Industries | Outperform |
13
|
$7.49 | Buy/Sell | $12.63 | 16.82% |
ACT Stock Forecast | AlzChem Group | Buy |
18
|
29.00€ | Buy/Sell | 33.00€ | 32.76% |
AMTX Stock Forecast | Aemetis | Outperform |
10
|
$3.21 | Buy/Sell | $11.64 | 102.49% |
Balchem EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's EBITDA has grown by 30.87%, rising from $164.16M to $214.83M. For next year, analysts predict EBITDA of $242.35M, which would mean an increase of 12.81%. Over the next seven years, experts predict that Balchem's EBITDA will grow at a rate of 9.90%.
Balchem EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's EBIT has grown by 41.30%, rising from $113.16M to $159.90M. For next year, analysts predict EBIT of $179.93M, which would mean an increase of 12.53%. Over the next seven years, experts predict that Balchem's EBIT will grow at a rate of 7.35%.
Balchem EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Balchem's EPS has fallen from $3.32 to $0.00 – a 100.00% decrease. The next year looks promising for Balchem, with analysts predicting EPS of $4.06 – an increase of 100.00%. Over the next seven years, experts anticipate that Balchem's EPS will grow at a rate of 100.00%.